Page last updated: 2024-08-21

cyproterone acetate and Benign Meningeal Neoplasms

cyproterone acetate has been researched along with Benign Meningeal Neoplasms in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (3.85)	29.6817
2010's	10 (38.46)	24.3611
2020's	15 (57.69)	2.80

Authors

Authors	Studies
Aboukais, R; Bourgeois, P; Caron, S; De Witte, O; Devalckeneer, A; Lejeune, JP; Maurage, CA; Perbet, R; Racape, J	1
Abbritti, R; Adle-Biassette, H; Bernat, AL; Bourneix, C; Froelich, S; Giammattei, L; Le Van, T; Mandonnet, E; Masliah-Planchon, J; Passeri, T; Perrier, A; Polivka, M; Wong, J	1
Hage, M; Lemaire, I; Plesa, O; Raffin Sanson, ML	1
Kirollos, R; Lee, KS; Nga, VDW; Santarius, T; Yeo, TT; Zhang, JJY	1
Coste, J; Duranteau, L; Froelich, S; Hoisnard, L; Laanani, M; Passeri, T; Weill, A; Zureik, M	1
Kareem, R; Majid, Z	1
Abbritti, R; Bernat, AL; Florea, SM; Fontanel, S; Froelich, S; Funck-Brentano, T; Mandonnet, E; Passeri, T; Weill, A; Yoldjian, I	1
Abi-Jaoude, S; Bielle, F; Blouin, A; Boetto, J; Cômes, PC; Ducos, Y; Huard, S; Kalamarides, M; Le Van, T; Marijon, P; Peyre, M; Teranishi, Y; Tran, S; Venot, Q	1
Amelot, A; Buffenoir, K; Cariou, B; Drui, D; Hadjadj, S; Loussouarn, D; Lugat, A; Primot, C; Roualdes, V; Samarut, E; Scharbarg, E; Thillays, F	1
Champeaux-Depond, C; Froelich, S; Sartor, A; Weller, J	1
Bernat, AL; Cadier, B; Coste, J; Duranteau, L; Fontanel, S; Froelich, S; Labidi, M; Nguyen, P; Passeri, T; Weill, A; Yoldjian, I	1
AbiJaoude, S; Cornu, P; Kalamarides, M; Marijon, P; Peyre, M; Roblot, P; Tran, S	1
Barraud, S; Batchinsky-Parrou, V; Kleiber, JC; Litre, F	1
Albarel, F; Appay, R; Boissonneau, S; Boucekine, M; Brue, T; Castinetti, F; Cuny, T; Dufour, H; Farah, K; Figarella-Branger, D; Fuentes, S; Graillon, T; Meyer, M; Morange, I; Peyrière, H	1
Greiber, IK; Hilden, M; Lidegaard, Ø; Mikkelsen, AP; Scheller, NM	1
Coati, I; Mancini, I; Martelli, V; Meriggiola, MC; Rotilio, A; Seracchioli, R	1
Baussart, B; Bielle, F; Boch, AL; Cazabat, L; de Marcellus, C; Gaillard, S; Giry, M; Kalamarides, M; Loiseau, H; Peyre, M; Raffin-Sanson, ML; Sanson, M; Villa, C	1
Schmutz, JL	1
Champagne, PO; Froelich, S; Passeri, T	1
Botella, C; Coll, G; Irthum, B; Lemaire, JJ	1
Bernat, AL; Froelich, S; George, B; Hamdi, S; Mandonnet, E; Oyama, K; Pocard, M; Vexiau, D	1
Alderman, CP	1
Aboukais, R; LE Rhun, E; Lejeune, JP; Marinho, P; Maurage, CA; Zairi, F	1
Boyer, P; Cebula, H; Froelich, S; Pham, TQ	1
Blenk, T; Cea-Soriano, L; Rodríguez, LA; Wallander, MA	1
Galarza, M; Gazzeri, G; Gazzeri, R	1

Reviews

3 review(s) available for cyproterone acetate and Benign Meningeal Neoplasms

Article	Year
Estrogen and Progesterone Therapy and Meningiomas. Endocrinology, 2022, 02-01, Volume: 163, Issue:2 Topics: Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Estrogens; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Postmenopause; Progesterone; Receptors, Estrogen; Receptors, Progesterone	2022
A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas. Scientific reports, 2022, 02-04, Volume: 12, Issue:1 Topics: Androgen Antagonists; Cyproterone Acetate; Female; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Observational Studies as Topic; Risk Assessment; Risk Factors	2022
Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:6 Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Estradiol; Female; Gonadal Steroid Hormones; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Transgender Persons; Transsexualism	2018

Other Studies

23 other study(ies) available for cyproterone acetate and Benign Meningeal Neoplasms

Article	Year
Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - Monocentric ongoing study on progestin related meningiomas. Clinical neurology and neurosurgery, 2021, Volume: 210 Topics: Adult; Aged; Chlormadinone Acetate; Cyproterone Acetate; Female; Humans; Magnetic Resonance Imaging; Male; Megestrol; Meningeal Neoplasms; Meningioma; Middle Aged; Norpregnadienes; Retrospective Studies	2021
Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization. Acta neurochirurgica, 2022, Volume: 164, Issue:1 Topics: Cyproterone Acetate; Female; Humans; Meningeal Neoplasms; Meningioma; Retrospective Studies; Skull Base Neoplasms	2022
Risk of intracranial meningioma with three potent progestogens: A population-based case-control study. European journal of neurology, 2022, Volume: 29, Issue:9 Topics: Case-Control Studies; Cyproterone Acetate; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Progestins	2022
Is cyproterone acetate causing intracranial meningiomas? JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:10 Topics: Cyproterone Acetate; Humans; Meningeal Neoplasms; Meningioma	2022
Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation. Journal of neurosurgery, 2023, 10-01, Volume: 139, Issue:4 Topics: Cyproterone Acetate; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Progestins	2023
Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesis. Cancer gene therapy, 2023, Volume: 30, Issue:8 Topics: Animals; Breast Neoplasms; Cell Transformation, Neoplastic; Class I Phosphatidylinositol 3-Kinases; Cyproterone Acetate; Female; Humans; Meningeal Neoplasms; Meningioma; Mice; Mutation	2023
Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma. Journal of neuro-oncology, 2021, Volume: 152, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Cohort Studies; Cyproterone Acetate; Female; France; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neurosurgical Procedures; Radiotherapy; Retrospective Studies; Young Adult	2021
Cyproterone acetate and meningioma: a nationwide-wide population based study. Journal of neuro-oncology, 2021, Volume: 151, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Case-Control Studies; Combined Modality Therapy; Cyproterone Acetate; Female; Follow-Up Studies; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Neurosurgical Procedures; Prognosis; Retrospective Studies	2021
Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ (Clinical research ed.), 2021, 02-03, Volume: 372 Topics: Adolescent; Adult; Aged; Androgen Antagonists; Case-Control Studies; Child; Cyproterone Acetate; Databases, Factual; Dose-Response Relationship, Drug; Female; France; Humans; Incidence; Longitudinal Studies; Meningeal Neoplasms; Meningioma; Middle Aged; Risk Assessment; Young Adult	2021
Sustained growth of intraosseous hormone-associated meningiomas after cessation of progestin therapy. Acta neurochirurgica, 2021, Volume: 163, Issue:6 Topics: Cell Proliferation; Cyproterone Acetate; Female; Humans; Magnetic Resonance Imaging; Male; Megestrol; Meningeal Neoplasms; Meningioma; Middle Aged; Progestins	2021
First case of cyproterone acetate induced multiple meningiomas in identical female twins: A case report. Neuro-Chirurgie, 2022, Volume: 68, Issue:3 Topics: Cyproterone; Cyproterone Acetate; Female; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Progestins; Twins, Monozygotic	2022
Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome. Neuro-Chirurgie, 2021, Volume: 67, Issue:6 Topics: Cyproterone Acetate; Humans; Meningeal Neoplasms; Meningioma; Progestins; Skull Base	2021
Cyproterone acetate and risk of meningioma: a nationwide cohort study. Journal of neurology, neurosurgery, and psychiatry, 2022, Volume: 93, Issue:2 Topics: Adolescent; Androgen Antagonists; Cohort Studies; Cyproterone Acetate; Denmark; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Prospective Studies	2022
Progestin-associated shift of meningioma mutational landscape. Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 03-01, Volume: 29, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Chlormadinone Acetate; Class I Phosphatidylinositol 3-Kinases; Cyproterone Acetate; DNA Mutational Analysis; Female; Humans; Megestrol Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Mutation; Progesterone Congeners; Retrospective Studies; Young Adult	2018
[Cyproterone acetate and meningioma: The latest findings]. Annales de dermatologie et de venereologie, 2018, Volume: 145, Issue:5 Topics: Androgen Antagonists; Cyproterone Acetate; Humans; Meningeal Neoplasms; Meningioma	2018
Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report. Acta neurochirurgica, 2019, Volume: 161, Issue:3 Topics: Cyproterone Acetate; Female; Humans; Megestrol; Meningeal Neoplasms; Meningioma; Middle Aged; Norpregnadienes	2019
[Intra cranial meningiomas and long term use of cyproterone acetate with a conventional dose in women. A report of two cases of tumor decrease after treatment withdrawal]. Neuro-Chirurgie, 2015, Volume: 61, Issue:5 Topics: Adult; Cyproterone; Cyproterone Acetate; Female; Humans; Meningeal Neoplasms; Meningioma; Treatment Outcome; Withholding Treatment	2015
Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients. Acta neurochirurgica, 2015, Volume: 157, Issue:10 Topics: Adult; Antineoplastic Agents; Cyproterone Acetate; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged	2015
Probable Drug-Related Meningioma Detected During the Course of Medication Review Services. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2016, Volume: 31, Issue:9 Topics: Androgen Antagonists; Australia; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Utilization Review; Humans; Intellectual Disability; Male; Meningeal Neoplasms; Meningioma	2016
Close follow-up after discontinuation of cyproterone acetate: a possible option to defer surgery in patients with voluminous intracranial meningioma. Journal of neurosurgical sciences, 2017, Volume: 61, Issue:1 Topics: Brain; Cyproterone Acetate; Female; Follow-Up Studies; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Time Factors	2017
Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient. Acta neurochirurgica, 2010, Volume: 152, Issue:11 Topics: Androgen Antagonists; Cyproterone Acetate; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Transsexualism	2010
Hormonal therapies and meningioma: is there a link? Cancer epidemiology, 2012, Volume: 36, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Hormone Replacement Therapy; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Retrospective Studies; Risk Factors; Young Adult	2012
Growth of a meningioma in a transsexual patient after estrogen-progestin therapy. The New England journal of medicine, 2007, Dec-06, Volume: 357, Issue:23 Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Transsexualism	2007